Preoperative contralateral lung radiation dose is associated with postoperative pulmonary toxicity in patients with locally advanced non-small cell lung cancer treated with trimodality therapy

被引:2
作者
Guo, Wenji [1 ]
Hui, Xuan [1 ]
Alfaifi, Salem [1 ]
Anderson, Lori [1 ]
Robertson, Scott [1 ]
Hales, Russell [1 ]
Hu, Chen [1 ]
McNutt, Todd [1 ]
Broderick, Stephen [2 ]
Naidoo, Jarushka [3 ]
Battafarano, Richard [2 ]
Yang, Stephen [2 ]
Voong, K. Ranh [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Surg, Div Thorac Surg, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA
关键词
INTENSITY-MODULATED RADIOTHERAPY; VOLUME HISTOGRAM PARAMETERS; CONCURRENT CHEMORADIATION; PNEUMONITIS; MESOTHELIOMA; ESCALATION; EXPERIENCE; SURGERY; NSCLC; TRIAL;
D O I
10.1016/j.prro.2018.01.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: In patients with non-small cell lung cancer (NSCLC) who undergo trimodality therapy (chemoradiation followed by surgical resection), it is unknown whether limiting preoperative radiation dose to the uninvolved lung reduces postsurgical morbidity. This study evaluated whether radiation fall-off dose parameters to the contralateral lung that is unaffected by NSCLC are associated with postoperative complications in NSCLC patients treated with trimodality therapy. Methods and materials: We retrospectively reviewed NSCLC patients who underwent trimodality therapy between March 2008 and October 2016, with available restored digital radiation plans. Fischer's exact test was used to assess associations between patient and treatment characteristics and the development of treatment-related toxicity. Spearman rank correlation was used to measure the strength of association between dosimetric parameters. Results: Forty-six patients were identified who received trimodality therapy with intensity modulated radiation (median, 59.4 Gy; range, 45-70) and concurrent platinum doublet chemotherapy, followed by surgical resection. The median age was 64.9 years (range, 45.6-81.6). The median follow-up time was 1.9 years (range, 0.3-8.4). Twenty-four (52.2%) patients developed any-grade pulmonary toxicity and 14 (30.4%) patients developed grade 2+ pulmonary toxicity. There was an increased incidence of any-grade pulmonary toxicity in patients with contralateral lung volume receiving at least 20 Gy (V20) >= 7% compared with <7% (90%, n = 9 vs 41.7%, n = 15;P = .01). Similarly, contralateral lung V10 >= 20% was associated with an increased rate of any-grade pulmonary toxicity compared with V 10 <20% (80%, n = 12 vs 38.7%, n = 12; P = .01). Pneumonectomy/bilobectomy was associated with grade 2+ pulmonary toxicity (P = .04). Conclusions: Patients who received a higher radiation fall-off dose volume parameter (V20 >= 7% and V10 >= 20%) to the contralateral uninvolved lung had a higher incidence of any-grade postoperative pulmonary toxicity. Limiting radiation fall-off dose to the uninvolved lung may be an important modifiable radiation parameter in limiting postoperative toxicity in trimodality patients. (C) 2018 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:E239 / E248
页数:10
相关论文
共 22 条
  • [1] Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
    Albain, Kathy S.
    Swann, R. Suzanne
    Rusch, Valerie W.
    Turrisi, Andrew T., III
    Shepherd, Frances A.
    Smith, Colum
    Chen, Yuhchyau
    Livingston, Robert B.
    Feins, Richard H.
    Gandara, David R.
    Fry, Willard A.
    Darling, Gail
    Johnson, David H.
    Green, Mark R.
    Miller, Robert C.
    Ley, Joanne
    Sause, Willliam T.
    Cox, James D.
    [J]. LANCET, 2009, 374 (9687) : 379 - 386
  • [2] Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma
    Allen, AM
    Czerminska, M
    Jänne, PA
    Sugarbaker, DJ
    Bueno, R
    Harris, JR
    Court, L
    Baldini, EH
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03): : 640 - 645
  • [3] DOSE-VOLUME ANALYSIS OF RADIATION PNEUMONITIS IN NON-SMALL-CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CISPLATINUM AND ETOPOSIDE WITH OR WITHOUT CONSOLIDATION DOCETAXEL
    Barriger, R. Bryan
    Fakiris, Achilles J.
    Hanna, Nasser
    Yu, Menggang
    Mantravadi, Prasad
    McGarry, Ronald C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (05): : 1381 - 1386
  • [4] Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
    Curran, Walter J., Jr.
    Paulus, Rebecca
    Langer, Corey J.
    Komaki, Ritsuko
    Lee, Jin S.
    Hauser, Stephen
    Movsas, Benjamin
    Wasserman, Todd
    Rosenthal, Seth A.
    Gore, Elizabeth
    Machtay, Mitchell
    Sause, William
    Cox, James D.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (19) : 1452 - 1460
  • [5] Multimodality therapy for stage III non-small-cell lung cancer
    Farray, D
    Mirkovic, N
    Albain, KS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) : 3257 - 3269
  • [6] Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
    Graham, MV
    Purdy, JA
    Emami, B
    Harms, W
    Bosch, W
    Lockett, MA
    Perez, CA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02): : 323 - 329
  • [7] Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis
    Kong, Feng-Ming
    Hayman, James A.
    Griffith, Kent A.
    Kalemkerian, Gregory P.
    Arenberg, Douglas
    Lyons, Susan
    Turrisi, Andrew
    Lichter, Allen
    Fraass, Benedick
    Eisbruch, Avraham
    Lawrence, Theodore S.
    Ten Haken, Randall K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04): : 1075 - 1086
  • [8] Toxicity and dosimetric analysis of non-small cell lung cancer patients undergoing radiotherapy with 4DCT and image-guided intensity modulated radiotherapy: a regional centre's experience
    Livingston, Gareth C.
    Last, Andrew J.
    Shakespeare, Thomas P.
    Dwyer, Patrick M.
    Westhuyzen, Justin
    McKay, Michael J.
    Connors, Lisa
    Leader, Stephanie
    Greenham, Stuart
    [J]. JOURNAL OF MEDICAL RADIATION SCIENCES, 2016, 63 (03) : 170 - 178
  • [9] Intensity-modulated radiotherapy for resected mesothelioma: The Duke experience
    Miles, Edward F.
    Larrier, Nicole A.
    Kelsey, Christopher R.
    Hubbs, Jessica L.
    Ma, Jinli
    Yoo, Sua
    Marks, Lawrence B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (04): : 1143 - 1150
  • [10] National Cancer Institute, COMM TERM CRIT ADV E